Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 62,600 shares at $45.49 ($2.9M) on 2024-08-30, disclosed to the SEC on 2024-09-04.
Scheduled sale ($2.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.49 | 25,096 | $1.1M | 40.0% |
| 2 | $45.49 | 25,096 | $1.1M | 40.0% |
| 3 | $46.01 | 6,204 | $285K | 10.0% |
| 4 | $46.01 | 6,204 | $285K | 10.0% |
| Total | $45.59 avg | 62,600 | $2.9M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |